PROVIDER PROFILE · NPI 1932198405

George VelikyOD

OptometryIselin, NJI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

1,482

Unique beneficiaries

—

Total services

1,872

Distinct HCPCS

Medicare payment

$109K

Peer benchmark

Total Medicare services vs. 865 Optometry providers in NJ — top quintile (cohort median 305).

PRESCRIBING · PART D · 2024

Total Rx claims

1,640

Beneficiaries

—

Total drug cost

$176K

Distinct drugs

Brand share

34.7%

Top prescribed drugs

Latanoprost548 claims

Timolol Maleate287 claims

Dorzolamide Hcl/Timolol Maleat249 claims

Bimatoprost152 claims

Prednisolone Acetate92 claims

QUALITY · MIPS · 2024

Final MIPS score

88.9

Quality

87.1

Cost

78.2

Improvement activities

40.0

Promoting interop.

92.0

Payment adjustment

0.59%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$1K

Payment records

By payment type

Food and Beverage$1K

REFERRAL NETWORK

Where George Veliky's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 5 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Laboratory Corporation Of America Holdings Clinical Laboratory · Raritan, NJ	40	54
Enas Tuppo Family Practice · Hawthrone, NJ	24	47
Jie Zhou Anesthesiology · Denville, NJ	22	32
Ilana Kipnis Anesthesiology · Englewood, NJ	21	33
Bioreference Health, Llc Clinical Laboratory · Elmwood Park, NJ	18	31

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history